Graft vs Host Disease

Pediatric cGVHD Symptom Scale

Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease

High Dose Chemotherapy and Autologous Transplant for Breast Cancer

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.

Optoacoustic Detection of Inflammation Using MSOT Device

A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host Disease After Allo-HSCT

Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Fecal Microbiota Transplantation for Steroid-Refractory Acute GI GVHD

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

Horizons Chronic Graft-Versus-Host-Disease Study

A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression

Evaluation of the Impact of Reduced Immunosuppression

Chronic GVHD Response Measures Validation

Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)

Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial